Global Pulmonary Drug Delivery Systems Market Growth 2022-2028
As the global economy mends, the 2021 growth of Pulmonary Drug Delivery Systems will have significant change from previous year. According to our latest study, the global Pulmonary Drug Delivery Systems market size is USD million in 2022 from USD 2979.8 million in 2021, with a change of % between 2021 and 2022. The global Pulmonary Drug Delivery Systems market size will reach USD 4016.5 million in 2028, growing at a CAGR of 4.4% over the analysis period.
The United States Pulmonary Drug Delivery Systems market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Pulmonary Drug Delivery Systems market, reaching US$ million by the year 2028. As for the Europe Pulmonary Drug Delivery Systems landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Pulmonary Drug Delivery Systems players cover 3M, GSK, AstraZeneca, and Cipla, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Pulmonary Drug Delivery Systems market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Nebulizers
Dry Powder Inhaler (DPI)
Metered Dose Inhaler (MDI)
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
COPD
Asthma
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
3M
GSK
AstraZeneca
Cipla
Chiesi
Boehringer Ingelheim
Aptar
Novartis
Philips Respironics
Omron Healthcare
PARI
Skyepharma
CareFusion
Shanghai Huarui
Taian Character
Chia Tai Tianqing
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pulmonary Drug Delivery Systems Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Pulmonary Drug Delivery Systems by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Pulmonary Drug Delivery Systems by Country/Region, 2017, 2022 & 2028
2.2 Pulmonary Drug Delivery Systems Segment by Type
2.2.1 Nebulizers
2.2.2 Dry Powder Inhaler (DPI)
2.2.3 Metered Dose Inhaler (MDI)
2.3 Pulmonary Drug Delivery Systems Sales by Type
2.3.1 Global Pulmonary Drug Delivery Systems Sales Market Share by Type (2017-2022)
2.3.2 Global Pulmonary Drug Delivery Systems Revenue and Market Share by Type (2017-2022)
2.3.3 Global Pulmonary Drug Delivery Systems Sale Price by Type (2017-2022)
2.4 Pulmonary Drug Delivery Systems Segment by Application
2.4.1 COPD
2.4.2 Asthma
2.4.3 Others
2.5 Pulmonary Drug Delivery Systems Sales by Application
2.5.1 Global Pulmonary Drug Delivery Systems Sale Market Share by Application (2017-2022)
2.5.2 Global Pulmonary Drug Delivery Systems Revenue and Market Share by Application (2017-2022)
2.5.3 Global Pulmonary Drug Delivery Systems Sale Price by Application (2017-2022)
3 Global Pulmonary Drug Delivery Systems by Company
3.1 Global Pulmonary Drug Delivery Systems Breakdown Data by Company
3.1.1 Global Pulmonary Drug Delivery Systems Annual Sales by Company (2020-2022)
3.1.2 Global Pulmonary Drug Delivery Systems Sales Market Share by Company (2020-2022)
3.2 Global Pulmonary Drug Delivery Systems Annual Revenue by Company (2020-2022)
3.2.1 Global Pulmonary Drug Delivery Systems Revenue by Company (2020-2022)
3.2.2 Global Pulmonary Drug Delivery Systems Revenue Market Share by Company (2020-2022)
3.3 Global Pulmonary Drug Delivery Systems Sale Price by Company
3.4 Key Manufacturers Pulmonary Drug Delivery Systems Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pulmonary Drug Delivery Systems Product Location Distribution
3.4.2 Players Pulmonary Drug Delivery Systems Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Pulmonary Drug Delivery Systems by Geographic Region
4.1 World Historic Pulmonary Drug Delivery Systems Market Size by Geographic Region (2017-2022)
4.1.1 Global Pulmonary Drug Delivery Systems Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Pulmonary Drug Delivery Systems Annual Revenue by Geographic Region
4.2 World Historic Pulmonary Drug Delivery Systems Market Size by Country/Region (2017-2022)
4.2.1 Global Pulmonary Drug Delivery Systems Annual Sales by Country/Region (2017-2022)
4.2.2 Global Pulmonary Drug Delivery Systems Annual Revenue by Country/Region
4.3 Americas Pulmonary Drug Delivery Systems Sales Growth
4.4 APAC Pulmonary Drug Delivery Systems Sales Growth
4.5 Europe Pulmonary Drug Delivery Systems Sales Growth
4.6 Middle East & Africa Pulmonary Drug Delivery Systems Sales Growth
5 Americas
5.1 Americas Pulmonary Drug Delivery Systems Sales by Country
5.1.1 Americas Pulmonary Drug Delivery Systems Sales by Country (2017-2022)
5.1.2 Americas Pulmonary Drug Delivery Systems Revenue by Country (2017-2022)
5.2 Americas Pulmonary Drug Delivery Systems Sales by Type
5.3 Americas Pulmonary Drug Delivery Systems Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pulmonary Drug Delivery Systems Sales by Region
6.1.1 APAC Pulmonary Drug Delivery Systems Sales by Region (2017-2022)
6.1.2 APAC Pulmonary Drug Delivery Systems Revenue by Region (2017-2022)
6.2 APAC Pulmonary Drug Delivery Systems Sales by Type
6.3 APAC Pulmonary Drug Delivery Systems Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Pulmonary Drug Delivery Systems by Country
7.1.1 Europe Pulmonary Drug Delivery Systems Sales by Country (2017-2022)
7.1.2 Europe Pulmonary Drug Delivery Systems Revenue by Country (2017-2022)
7.2 Europe Pulmonary Drug Delivery Systems Sales by Type
7.3 Europe Pulmonary Drug Delivery Systems Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Pulmonary Drug Delivery Systems by Country
8.1.1 Middle East & Africa Pulmonary Drug Delivery Systems Sales by Country (2017-2022)
8.1.2 Middle East & Africa Pulmonary Drug Delivery Systems Revenue by Country (2017-2022)
8.2 Middle East & Africa Pulmonary Drug Delivery Systems Sales by Type
8.3 Middle East & Africa Pulmonary Drug Delivery Systems Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pulmonary Drug Delivery Systems
10.3 Manufacturing Process Analysis of Pulmonary Drug Delivery Systems
10.4 Industry Chain Structure of Pulmonary Drug Delivery Systems
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pulmonary Drug Delivery Systems Distributors
11.3 Pulmonary Drug Delivery Systems Customer
12 World Forecast Review for Pulmonary Drug Delivery Systems by Geographic Region
12.1 Global Pulmonary Drug Delivery Systems Market Size Forecast by Region
12.1.1 Global Pulmonary Drug Delivery Systems Forecast by Region (2023-2028)
12.1.2 Global Pulmonary Drug Delivery Systems Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Pulmonary Drug Delivery Systems Forecast by Type
12.7 Global Pulmonary Drug Delivery Systems Forecast by Application
13 Key Players Analysis
13.1 3M
13.1.1 3M Company Information
13.1.2 3M Pulmonary Drug Delivery Systems Product Offered
13.1.3 3M Pulmonary Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 3M Main Business Overview
13.1.5 3M Latest Developments
13.2 GSK
13.2.1 GSK Company Information
13.2.2 GSK Pulmonary Drug Delivery Systems Product Offered
13.2.3 GSK Pulmonary Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 GSK Main Business Overview
13.2.5 GSK Latest Developments
13.3 AstraZeneca
13.3.1 AstraZeneca Company Information
13.3.2 AstraZeneca Pulmonary Drug Delivery Systems Product Offered
13.3.3 AstraZeneca Pulmonary Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 AstraZeneca Main Business Overview
13.3.5 AstraZeneca Latest Developments
13.4 Cipla
13.4.1 Cipla Company Information
13.4.2 Cipla Pulmonary Drug Delivery Systems Product Offered
13.4.3 Cipla Pulmonary Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Cipla Main Business Overview
13.4.5 Cipla Latest Developments
13.5 Chiesi
13.5.1 Chiesi Company Information
13.5.2 Chiesi Pulmonary Drug Delivery Systems Product Offered
13.5.3 Chiesi Pulmonary Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Chiesi Main Business Overview
13.5.5 Chiesi Latest Developments
13.6 Boehringer Ingelheim
13.6.1 Boehringer Ingelheim Company Information
13.6.2 Boehringer Ingelheim Pulmonary Drug Delivery Systems Product Offered
13.6.3 Boehringer Ingelheim Pulmonary Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Boehringer Ingelheim Main Business Overview
13.6.5 Boehringer Ingelheim Latest Developments
13.7 Aptar
13.7.1 Aptar Company Information
13.7.2 Aptar Pulmonary Drug Delivery Systems Product Offered
13.7.3 Aptar Pulmonary Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Aptar Main Business Overview
13.7.5 Aptar Latest Developments
13.8 Novartis
13.8.1 Novartis Company Information
13.8.2 Novartis Pulmonary Drug Delivery Systems Product Offered
13.8.3 Novartis Pulmonary Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Novartis Main Business Overview
13.8.5 Novartis Latest Developments
13.9 Philips Respironics
13.9.1 Philips Respironics Company Information
13.9.2 Philips Respironics Pulmonary Drug Delivery Systems Product Offered
13.9.3 Philips Respironics Pulmonary Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Philips Respironics Main Business Overview
13.9.5 Philips Respironics Latest Developments
13.10 Omron Healthcare
13.10.1 Omron Healthcare Company Information
13.10.2 Omron Healthcare Pulmonary Drug Delivery Systems Product Offered
13.10.3 Omron Healthcare Pulmonary Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Omron Healthcare Main Business Overview
13.10.5 Omron Healthcare Latest Developments
13.11 PARI
13.11.1 PARI Company Information
13.11.2 PARI Pulmonary Drug Delivery Systems Product Offered
13.11.3 PARI Pulmonary Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 PARI Main Business Overview
13.11.5 PARI Latest Developments
13.12 Skyepharma
13.12.1 Skyepharma Company Information
13.12.2 Skyepharma Pulmonary Drug Delivery Systems Product Offered
13.12.3 Skyepharma Pulmonary Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Skyepharma Main Business Overview
13.12.5 Skyepharma Latest Developments
13.13 CareFusion
13.13.1 CareFusion Company Information
13.13.2 CareFusion Pulmonary Drug Delivery Systems Product Offered
13.13.3 CareFusion Pulmonary Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 CareFusion Main Business Overview
13.13.5 CareFusion Latest Developments
13.14 Shanghai Huarui
13.14.1 Shanghai Huarui Company Information
13.14.2 Shanghai Huarui Pulmonary Drug Delivery Systems Product Offered
13.14.3 Shanghai Huarui Pulmonary Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Shanghai Huarui Main Business Overview
13.14.5 Shanghai Huarui Latest Developments
13.15 Taian Character
13.15.1 Taian Character Company Information
13.15.2 Taian Character Pulmonary Drug Delivery Systems Product Offered
13.15.3 Taian Character Pulmonary Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Taian Character Main Business Overview
13.15.5 Taian Character Latest Developments
13.16 Chia Tai Tianqing
13.16.1 Chia Tai Tianqing Company Information
13.16.2 Chia Tai Tianqing Pulmonary Drug Delivery Systems Product Offered
13.16.3 Chia Tai Tianqing Pulmonary Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Chia Tai Tianqing Main Business Overview
13.16.5 Chia Tai Tianqing Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Pulmonary Drug Delivery Systems Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Pulmonary Drug Delivery Systems Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Nebulizers
Table 4. Major Players of Dry Powder Inhaler (DPI)
Table 5. Major Players of Metered Dose Inhaler (MDI)
Table 6. Global Pulmonary Drug Delivery Systems Sales by Type (2017-2022) & (M Units)
Table 7. Global Pulmonary Drug Delivery Systems Sales Market Share by Type (2017-2022)
Table 8. Global Pulmonary Drug Delivery Systems Revenue by Type (2017-2022) & ($ million)
Table 9. Global Pulmonary Drug Delivery Systems Revenue Market Share by Type (2017-2022)
Table 10. Global Pulmonary Drug Delivery Systems Sale Price by Type (2017-2022) & (US$/Unit)
Table 11. Global Pulmonary Drug Delivery Systems Sales by Application (2017-2022) & (M Units)
Table 12. Global Pulmonary Drug Delivery Systems Sales Market Share by Application (2017-2022)
Table 13. Global Pulmonary Drug Delivery Systems Revenue by Application (2017-2022)
Table 14. Global Pulmonary Drug Delivery Systems Revenue Market Share by Application (2017-2022)
Table 15. Global Pulmonary Drug Delivery Systems Sale Price by Application (2017-2022) & (US$/Unit)
Table 16. Global Pulmonary Drug Delivery Systems Sales by Company (2020-2022) & (M Units)
Table 17. Global Pulmonary Drug Delivery Systems Sales Market Share by Company (2020-2022)
Table 18. Global Pulmonary Drug Delivery Systems Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Pulmonary Drug Delivery Systems Revenue Market Share by Company (2020-2022)
Table 20. Global Pulmonary Drug Delivery Systems Sale Price by Company (2020-2022) & (US$/Unit)
Table 21. Key Manufacturers Pulmonary Drug Delivery Systems Producing Area Distribution and Sales Area
Table 22. Players Pulmonary Drug Delivery Systems Products Offered
Table 23. Pulmonary Drug Delivery Systems Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Pulmonary Drug Delivery Systems Sales by Geographic Region (2017-2022) & (M Units)
Table 27. Global Pulmonary Drug Delivery Systems Sales Market Share Geographic Region (2017-2022)
Table 28. Global Pulmonary Drug Delivery Systems Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Pulmonary Drug Delivery Systems Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Pulmonary Drug Delivery Systems Sales by Country/Region (2017-2022) & (M Units)
Table 31. Global Pulmonary Drug Delivery Systems Sales Market Share by Country/Region (2017-2022)
Table 32. Global Pulmonary Drug Delivery Systems Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Pulmonary Drug Delivery Systems Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Pulmonary Drug Delivery Systems Sales by Country (2017-2022) & (M Units)
Table 35. Americas Pulmonary Drug Delivery Systems Sales Market Share by Country (2017-2022)
Table 36. Americas Pulmonary Drug Delivery Systems Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Pulmonary Drug Delivery Systems Revenue Market Share by Country (2017-2022)
Table 38. Americas Pulmonary Drug Delivery Systems Sales by Type (2017-2022) & (M Units)
Table 39. Americas Pulmonary Drug Delivery Systems Sales Market Share by Type (2017-2022)
Table 40. Americas Pulmonary Drug Delivery Systems Sales by Application (2017-2022) & (M Units)
Table 41. Americas Pulmonary Drug Delivery Systems Sales Market Share by Application (2017-2022)
Table 42. APAC Pulmonary Drug Delivery Systems Sales by Region (2017-2022) & (M Units)
Table 43. APAC Pulmonary Drug Delivery Systems Sales Market Share by Region (2017-2022)
Table 44. APAC Pulmonary Drug Delivery Systems Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Pulmonary Drug Delivery Systems Revenue Market Share by Region (2017-2022)
Table 46. APAC Pulmonary Drug Delivery Systems Sales by Type (2017-2022) & (M Units)
Table 47. APAC Pulmonary Drug Delivery Systems Sales Market Share by Type (2017-2022)
Table 48. APAC Pulmonary Drug Delivery Systems Sales by Application (2017-2022) & (M Units)
Table 49. APAC Pulmonary Drug Delivery Systems Sales Market Share by Application (2017-2022)
Table 50. Europe Pulmonary Drug Delivery Systems Sales by Country (2017-2022) & (M Units)
Table 51. Europe Pulmonary Drug Delivery Systems Sales Market Share by Country (2017-2022)
Table 52. Europe Pulmonary Drug Delivery Systems Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Pulmonary Drug Delivery Systems Revenue Market Share by Country (2017-2022)
Table 54. Europe Pulmonary Drug Delivery Systems Sales by Type (2017-2022) & (M Units)
Table 55. Europe Pulmonary Drug Delivery Systems Sales Market Share by Type (2017-2022)
Table 56. Europe Pulmonary Drug Delivery Systems Sales by Application (2017-2022) & (M Units)
Table 57. Europe Pulmonary Drug Delivery Systems Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Pulmonary Drug Delivery Systems Sales by Country (2017-2022) & (M Units)
Table 59. Middle East & Africa Pulmonary Drug Delivery Systems Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Pulmonary Drug Delivery Systems Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Pulmonary Drug Delivery Systems Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Pulmonary Drug Delivery Systems Sales by Type (2017-2022) & (M Units)
Table 63. Middle East & Africa Pulmonary Drug Delivery Systems Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Pulmonary Drug Delivery Systems Sales by Application (2017-2022) & (M Units)
Table 65. Middle East & Africa Pulmonary Drug Delivery Systems Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Pulmonary Drug Delivery Systems
Table 67. Key Market Challenges & Risks of Pulmonary Drug Delivery Systems
Table 68. Key Industry Trends of Pulmonary Drug Delivery Systems
Table 69. Pulmonary Drug Delivery Systems Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Pulmonary Drug Delivery Systems Distributors List
Table 72. Pulmonary Drug Delivery Systems Customer List
Table 73. Global Pulmonary Drug Delivery Systems Sales Forecast by Region (2023-2028) & (M Units)
Table 74. Global Pulmonary Drug Delivery Systems Sales Market Forecast by Region
Table 75. Global Pulmonary Drug Delivery Systems Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Pulmonary Drug Delivery Systems Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Pulmonary Drug Delivery Systems Sales Forecast by Country (2023-2028) & (M Units)
Table 78. Americas Pulmonary Drug Delivery Systems Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Pulmonary Drug Delivery Systems Sales Forecast by Region (2023-2028) & (M Units)
Table 80. APAC Pulmonary Drug Delivery Systems Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Pulmonary Drug Delivery Systems Sales Forecast by Country (2023-2028) & (M Units)
Table 82. Europe Pulmonary Drug Delivery Systems Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Pulmonary Drug Delivery Systems Sales Forecast by Country (2023-2028) & (M Units)
Table 84. Middle East & Africa Pulmonary Drug Delivery Systems Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Pulmonary Drug Delivery Systems Sales Forecast by Type (2023-2028) & (M Units)
Table 86. Global Pulmonary Drug Delivery Systems Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Pulmonary Drug Delivery Systems Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Pulmonary Drug Delivery Systems Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Pulmonary Drug Delivery Systems Sales Forecast by Application (2023-2028) & (M Units)
Table 90. Global Pulmonary Drug Delivery Systems Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Pulmonary Drug Delivery Systems Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Pulmonary Drug Delivery Systems Revenue Market Share Forecast by Application (2023-2028)
Table 93. 3M Basic Information, Pulmonary Drug Delivery Systems Manufacturing Base, Sales Area and Its Competitors
Table 94. 3M Pulmonary Drug Delivery Systems Product Offered
Table 95. 3M Pulmonary Drug Delivery Systems Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 96. 3M Main Business
Table 97. 3M Latest Developments
Table 98. GSK Basic Information, Pulmonary Drug Delivery Systems Manufacturing Base, Sales Area and Its Competitors
Table 99. GSK Pulmonary Drug Delivery Systems Product Offered
Table 100. GSK Pulmonary Drug Delivery Systems Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 101. GSK Main Business
Table 102. GSK Latest Developments
Table 103. AstraZeneca Basic Information, Pulmonary Drug Delivery Systems Manufacturing Base, Sales Area and Its Competitors
Table 104. AstraZeneca Pulmonary Drug Delivery Systems Product Offered
Table 105. AstraZeneca Pulmonary Drug Delivery Systems Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 106. AstraZeneca Main Business
Table 107. AstraZeneca Latest Developments
Table 108. Cipla Basic Information, Pulmonary Drug Delivery Systems Manufacturing Base, Sales Area and Its Competitors
Table 109. Cipla Pulmonary Drug Delivery Systems Product Offered
Table 110. Cipla Pulmonary Drug Delivery Systems Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 111. Cipla Main Business
Table 112. Cipla Latest Developments
Table 113. Chiesi Basic Information, Pulmonary Drug Delivery Systems Manufacturing Base, Sales Area and Its Competitors
Table 114. Chiesi Pulmonary Drug Delivery Systems Product Offered
Table 115. Chiesi Pulmonary Drug Delivery Systems Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 116. Chiesi Main Business
Table 117. Chiesi Latest Developments
Table 118. Boehringer Ingelheim Basic Information, Pulmonary Drug Delivery Systems Manufacturing Base, Sales Area and Its Competitors
Table 119. Boehringer Ingelheim Pulmonary Drug Delivery Systems Product Offered
Table 120. Boehringer Ingelheim Pulmonary Drug Delivery Systems Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 121. Boehringer Ingelheim Main Business
Table 122. Boehringer Ingelheim Latest Developments
Table 123. Aptar Basic Information, Pulmonary Drug Delivery Systems Manufacturing Base, Sales Area and Its Competitors
Table 124. Aptar Pulmonary Drug Delivery Systems Product Offered
Table 125. Aptar Pulmonary Drug Delivery Systems Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 126. Aptar Main Business
Table 127. Aptar Latest Developments
Table 128. Novartis Basic Information, Pulmonary Drug Delivery Systems Manufacturing Base, Sales Area and Its Competitors
Table 129. Novartis Pulmonary Drug Delivery Systems Product Offered
Table 130. Novartis Pulmonary Drug Delivery Systems Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 131. Novartis Main Business
Table 132. Novartis Latest Developments
Table 133. Philips Respironics Basic Information, Pulmonary Drug Delivery Systems Manufacturing Base, Sales Area and Its Competitors
Table 134. Philips Respironics Pulmonary Drug Delivery Systems Product Offered
Table 135. Philips Respironics Pulmonary Drug Delivery Systems Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 136. Philips Respironics Main Business
Table 137. Philips Respironics Latest Developments
Table 138. Omron Healthcare Basic Information, Pulmonary Drug Delivery Systems Manufacturing Base, Sales Area and Its Competitors
Table 139. Omron Healthcare Pulmonary Drug Delivery Systems Product Offered
Table 140. Omron Healthcare Pulmonary Drug Delivery Systems Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 141. Omron Healthcare Main Business
Table 142. Omron Healthcare Latest Developments
Table 143. PARI Basic Information, Pulmonary Drug Delivery Systems Manufacturing Base, Sales Area and Its Competitors
Table 144. PARI Pulmonary Drug Delivery Systems Product Offered
Table 145. PARI Pulmonary Drug Delivery Systems Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 146. PARI Main Business
Table 147. PARI Latest Developments
Table 148. Skyepharma Basic Information, Pulmonary Drug Delivery Systems Manufacturing Base, Sales Area and Its Competitors
Table 149. Skyepharma Pulmonary Drug Delivery Systems Product Offered
Table 150. Skyepharma Pulmonary Drug Delivery Systems Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 151. Skyepharma Main Business
Table 152. Skyepharma Latest Developments
Table 153. CareFusion Basic Information, Pulmonary Drug Delivery Systems Manufacturing Base, Sales Area and Its Competitors
Table 154. CareFusion Pulmonary Drug Delivery Systems Product Offered
Table 155. CareFusion Pulmonary Drug Delivery Systems Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 156. CareFusion Main Business
Table 157. CareFusion Latest Developments
Table 158. Shanghai Huarui Basic Information, Pulmonary Drug Delivery Systems Manufacturing Base, Sales Area and Its Competitors
Table 159. Shanghai Huarui Pulmonary Drug Delivery Systems Product Offered
Table 160. Shanghai Huarui Pulmonary Drug Delivery Systems Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 161. Shanghai Huarui Main Business
Table 162. Shanghai Huarui Latest Developments
Table 163. Taian Character Basic Information, Pulmonary Drug Delivery Systems Manufacturing Base, Sales Area and Its Competitors
Table 164. Taian Character Pulmonary Drug Delivery Systems Product Offered
Table 165. Taian Character Pulmonary Drug Delivery Systems Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 166. Taian Character Main Business
Table 167. Taian Character Latest Developments
Table 168. Chia Tai Tianqing Basic Information, Pulmonary Drug Delivery Systems Manufacturing Base, Sales Area and Its Competitors
Table 169. Chia Tai Tianqing Pulmonary Drug Delivery Systems Product Offered
Table 170. Chia Tai Tianqing Pulmonary Drug Delivery Systems Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 171. Chia Tai Tianqing Main Business
Table 172. Chia Tai Tianqing Latest Developments
List of Figures
Figure 1. Picture of Pulmonary Drug Delivery Systems
Figure 2. Pulmonary Drug Delivery Systems Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pulmonary Drug Delivery Systems Sales Growth Rate 2017-2028 (M Units)
Figure 7. Global Pulmonary Drug Delivery Systems Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Pulmonary Drug Delivery Systems Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Nebulizers
Figure 10. Product Picture of Dry Powder Inhaler (DPI)
Figure 11. Product Picture of Metered Dose Inhaler (MDI)
Figure 12. Global Pulmonary Drug Delivery Systems Sales Market Share by Type in 2021
Figure 13. Global Pulmonary Drug Delivery Systems Revenue Market Share by Type (2017-2022)
Figure 14. Pulmonary Drug Delivery Systems Consumed in COPD
Figure 15. Global Pulmonary Drug Delivery Systems Market: COPD (2017-2022) & (M Units)
Figure 16. Pulmonary Drug Delivery Systems Consumed in Asthma
Figure 17. Global Pulmonary Drug Delivery Systems Market: Asthma (2017-2022) & (M Units)
Figure 18. Pulmonary Drug Delivery Systems Consumed in Others
Figure 19. Global Pulmonary Drug Delivery Systems Market: Others (2017-2022) & (M Units)
Figure 20. Global Pulmonary Drug Delivery Systems Sales Market Share by Application (2017-2022)
Figure 21. Global Pulmonary Drug Delivery Systems Revenue Market Share by Application in 2021
Figure 22. Pulmonary Drug Delivery Systems Revenue Market by Company in 2021 ($ Million)
Figure 23. Global Pulmonary Drug Delivery Systems Revenue Market Share by Company in 2021
Figure 24. Global Pulmonary Drug Delivery Systems Sales Market Share by Geographic Region (2017-2022)
Figure 25. Global Pulmonary Drug Delivery Systems Revenue Market Share by Geographic Region in 2021
Figure 26. Global Pulmonary Drug Delivery Systems Sales Market Share by Region (2017-2022)
Figure 27. Global Pulmonary Drug Delivery Systems Revenue Market Share by Country/Region in 2021
Figure 28. Americas Pulmonary Drug Delivery Systems Sales 2017-2022 (M Units)
Figure 29. Americas Pulmonary Drug Delivery Systems Revenue 2017-2022 ($ Millions)
Figure 30. APAC Pulmonary Drug Delivery Systems Sales 2017-2022 (M Units)
Figure 31. APAC Pulmonary Drug Delivery Systems Revenue 2017-2022 ($ Millions)
Figure 32. Europe Pulmonary Drug Delivery Systems Sales 2017-2022 (M Units)
Figure 33. Europe Pulmonary Drug Delivery Systems Revenue 2017-2022 ($ Millions)
Figure 34. Middle East & Africa Pulmonary Drug Delivery Systems Sales 2017-2022 (M Units)
Figure 35. Middle East & Africa Pulmonary Drug Delivery Systems Revenue 2017-2022 ($ Millions)
Figure 36. Americas Pulmonary Drug Delivery Systems Sales Market Share by Country in 2021
Figure 37. Americas Pulmonary Drug Delivery Systems Revenue Market Share by Country in 2021
Figure 38. United States Pulmonary Drug Delivery Systems Revenue Growth 2017-2022 ($ Millions)
Figure 39. Canada Pulmonary Drug Delivery Systems Revenue Growth 2017-2022 ($ Millions)
Figure 40. Mexico Pulmonary Drug Delivery Systems Revenue Growth 2017-2022 ($ Millions)
Figure 41. Brazil Pulmonary Drug Delivery Systems Revenue Growth 2017-2022 ($ Millions)
Figure 42. APAC Pulmonary Drug Delivery Systems Sales Market Share by Region in 2021
Figure 43. APAC Pulmonary Drug Delivery Systems Revenue Market Share by Regions in 2021
Figure 44. China Pulmonary Drug Delivery Systems Revenue Growth 2017-2022 ($ Millions)
Figure 45. Japan Pulmonary Drug Delivery Systems Revenue Growth 2017-2022 ($ Millions)
Figure 46. South Korea Pulmonary Drug Delivery Systems Revenue Growth 2017-2022 ($ Millions)
Figure 47. Southeast Asia Pulmonary Drug Delivery Systems Revenue Growth 2017-2022 ($ Millions)
Figure 48. India Pulmonary Drug Delivery Systems Revenue Growth 2017-2022 ($ Millions)
Figure 49. Australia Pulmonary Drug Delivery Systems Revenue Growth 2017-2022 ($ Millions)
Figure 50. Europe Pulmonary Drug Delivery Systems Sales Market Share by Country in 2021
Figure 51. Europe Pulmonary Drug Delivery Systems Revenue Market Share by Country in 2021
Figure 52. Germany Pulmonary Drug Delivery Systems Revenue Growth 2017-2022 ($ Millions)
Figure 53. France Pulmonary Drug Delivery Systems Revenue Growth 2017-2022 ($ Millions)
Figure 54. UK Pulmonary Drug Delivery Systems Revenue Growth 2017-2022 ($ Millions)
Figure 55. Italy Pulmonary Drug Delivery Systems Revenue Growth 2017-2022 ($ Millions)
Figure 56. Russia Pulmonary Drug Delivery Systems Revenue Growth 2017-2022 ($ Millions)
Figure 57. Middle East & Africa Pulmonary Drug Delivery Systems Sales Market Share by Country in 2021
Figure 58. Middle East & Africa Pulmonary Drug Delivery Systems Revenue Market Share by Country in 2021
Figure 59. Egypt Pulmonary Drug Delivery Systems Revenue Growth 2017-2022 ($ Millions)
Figure 60. South Africa Pulmonary Drug Delivery Systems Revenue Growth 2017-2022 ($ Millions)
Figure 61. Israel Pulmonary Drug Delivery Systems Revenue Growth 2017-2022 ($ Millions)
Figure 62. Turkey Pulmonary Drug Delivery Systems Revenue Growth 2017-2022 ($ Millions)
Figure 63. GCC Country Pulmonary Drug Delivery Systems Revenue Growth 2017-2022 ($ Millions)
Figure 64. Manufacturing Cost Structure Analysis of Pulmonary Drug Delivery Systems in 2021
Figure 65. Manufacturing Process Analysis of Pulmonary Drug Delivery Systems
Figure 66. Industry Chain Structure of Pulmonary Drug Delivery Systems
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles
